The impact of community-based non-pharmacological interventions on cardiovascular and kidney disease outcomes in remote dwelling Indigenous communities: A scoping review protocol.

The impact of community-based non-pharmacological interventions on cardiovascular and kidney disease outcomes in remote dwelling Indigenous communities: A scoping review protocol.
复制标题

DOI:
10.1371/journal.pone.0269839
复制
发表时间:
2022
期刊:
影响因子:
3.7
通讯作者:
--
中科院分区:
综合性期刊3区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

Indigenous people represent approximately 5% of the world’s population. However, they often have a disproportionately higher burden of cardiovascular disease (CVD) risk and chronic kidney disease (CKD) than their equivalent general population. Several non-pharmacological interventions (e.g., educational) have been used to reduce CVD and kidney disease risk factors in Indigenous groups. The aim of this paper is to describe the protocol for a scoping review that will assess the impact of non-pharmacological interventions carried out in Indigenous and remote dwelling populations to reduce CVD risk factors and CKD. This scoping review will be guided by the methodological framework for conducting scoping studies developed by Arksey and O’Malley. Both empirical (Medline, Embase, Cochrane Library, CINAHL, ISI Web of Science and PsycINFO) and grey literature references will be assessed if they focused on interventions targeted at reducing CVD or CKD among Indigenous groups. Two reviewers will independently screen references in consecutive stages of title/abstract screening and then full-text screening. Impact of interventions used will be assessed using the reach, effectiveness, adoption, implementation, maintenance (RE-AIM) framework. A descriptive overview, tabular summaries, and content analysis will be carried out on the extracted data. This review will collect and analyse evidence on the impact of interventions of research carried out to reduce CVD and CKD among Indigenous populations. Such evidence will be disseminated using traditional approaches that includes open-access peer-reviewed publication, scientific presentations, and a report. Also, we will disseminate our findings to the government and Indigenous leaders. Ethical approval will not be required for this scoping review as the data used will be extracted from already published studies with publicly accessible data.
DOI: 10.1016/j.jacl.2010.07.007
发表时间: 2010-09
影响因子: 4.4
作者:
Russell M;Silverman A;Fleg JL;Lee ET;Mete M;Weir M;Wilson C;Yeh F;Howard BV;Howard WM
通讯作者: Howard WM
DOI: 10.2105/ajph.89.9.1322
发表时间: 1999-09-01
影响因子: 12.7
作者:
Glasgow, RE;Vogt, TM;Boles, SM
通讯作者: Boles, SM
DOI: 10.1016/j.amepre.2005.08.037
发表时间: 2006-01-01
影响因子: 5.5
作者:
Glasgow, RE;Nelson, CC;King, DK
通讯作者: King, DK
DOI: 10.1186/s12882-020-02162-4
发表时间: 2020-11-19
期刊: BMC nephrology
影响因子: 2.3
作者:
Carswell C;Reid J;Walsh I;Johnston W;McAneney H;Mullan R;Lee JB;Nelson H;Matthews M;Weatherup E;Spencer A;Michelo J;Quail A;Kielty G;Mackenzie A;Elliott J;Arbuckle N;Wilson A;Noble H
通讯作者: Noble H
DOI: 10.5694/j.1326-5377.2000.tb124070.x
发表时间: 2000-05-15
影响因子: 11.4
作者:
Hoy, WE;Baker, PR;Wang, ZQ
通讯作者: Wang, ZQ